Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TARA | US
-0.08
-1.54%
Healthcare
Biotechnology
30/06/2024
16/04/2026
5.13
5.18
5.34
5.08
Protara Therapeutics Inc. a clinical-stage biopharmaceutical company engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002 an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics Inc. and changed its name to Protara Therapeutics Inc. in May 2020. The company is headquartered in New York New York.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
42.3%1 month
51.4%3 months
84.6%6 months
89.5%-
-
0.42
0.05
0.05
0.74
-
-
-43.90M
105.83M
105.83M
-
-
-
-
-45.91
13.38
13.83
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.60
Range1M
0.69
Range3M
2.78
Rel. volume
0.59
Price X volume
2.18M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 6.16 | 114.29M | -1.75% | n/a | 571.64% |
| Milestone Pharmaceuticals Inc | MIST | Biotechnology | 2.09 | 111.33M | -5.00% | n/a | 166.53% |
| Cellectar Biosciences Inc | CLRB | Biotechnology | 3.01 | 107.91M | -0.99% | n/a | 2.10% |
| Dermira Inc | DERM | Biotechnology | 5.17 | 107.16M | -2.45% | 47.08 | 201.92% |
| Aldeyra Therapeutics Inc | ALDX | Biotechnology | 1.8 | 106.96M | -1.64% | n/a | 15.90% |
| IN8bio Inc. Common Stock | INAB | Biotechnology | 1.45 | 105.19M | 3.57% | n/a | 43.30% |
| Pyxis Oncology Inc. Common Stock | PYXS | Biotechnology | 1.7 | 101.02M | -0.58% | n/a | 12.29% |
| Agenus Inc | AGEN | Biotechnology | 4.64 | 100.09M | -3.93% | n/a | -170.56% |
| Gossamer Bio Inc | GOSS | Biotechnology | 0.4374 | 98.95M | -2.99% | n/a | 243.93% |
| Surrozen Inc. Common Stock | SRZN | Biotechnology | 30.32 | 97.20M | -5.31% | n/a | 35.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.99 | 100.48M | 0.63% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.12 | 99.69M | 0.49% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.93 | 74.70M | 1.14% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.32 | 59.96M | 0.00% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 14 | 21.32M | 2.04% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.612 | 11.83M | -2.84% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.74 | 10.81M | 6.52% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.335 | 3.41M | -2.06% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2167 | 2.06M | -6.19% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.44 | 793.44K | -17.24% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.74 | - | Expensive |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.42 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 84.64 | - | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 105.83M | - | Emerging |